1. Jiang, Liqun, Chen, Suping, Stinnett, Victoria, Lin, Ming-Tseh, Zou, Ying S. 2021. Concomitance of a novel RMDN2-ALK fusion and an EML4-ALK fusion in a lung adenocarcinoma. In Cancer genetics, 258-259, 18-22. doi:10.1016/j.cancergen.2021.06.004. https://pubmed.ncbi.nlm.nih.gov/34233240/
2. Zhu, Xiaobo, Zou, Yixin, Jia, Linna, Yang, Sheng, Huang, Peng. 2023. Using multi-tissue transcriptome-wide association study to identify candidate susceptibility genes for respiratory infectious diseases. In Frontiers in genetics, 14, 1164274. doi:10.3389/fgene.2023.1164274. https://pubmed.ncbi.nlm.nih.gov/37020999/
3. Chen, Yanliang, Zhou, Chan, Zhang, Xiaoqiao, Wang, Dandan, Chen, Yong. 2025. Construction of a novel radioresistance-related signature for prediction of prognosis, immune microenvironment and anti-tumour drug sensitivity in non-small cell lung cancer. In Annals of medicine, 57, 2447930. doi:10.1080/07853890.2024.2447930. https://pubmed.ncbi.nlm.nih.gov/39797413/
4. Zang, Xiayan, Wang, Zihui, Li, Yafei, Zhu, Kuicheng, Xu, Cunshuan. 2023. Regulation of Hepatocytes in G0 and G1 Phases by NOTCH3 mRNA, miR-369-3p, and rno-Rmdn2_0006 during the Initial Stage of Rat Liver Regeneration. In Genetics research, 2023, 8779758. doi:10.1155/2023/8779758. https://pubmed.ncbi.nlm.nih.gov/37153858/
5. Andrade, Fernando, Nakata, Asuka, Gotoh, Noriko, Fujita, André. 2020. Large miRNA survival analysis reveals a prognostic four-biomarker signature for triple negative breast cancer. In Genetics and molecular biology, 43, e20180269. doi:10.1590/1678-4685-GMB-2018-0269. https://pubmed.ncbi.nlm.nih.gov/31487369/
6. Chen, Kun-Ming, Sun, Yuan-Wan, Kawasawa, Yuka Imamura, Atkins, Hannah, El-Bayoumy, Karam. 2020. Black Raspberry Inhibits Oral Tumors in Mice Treated with the Tobacco Smoke Constituent Dibenzo(def,p)chrysene Via Genetic and Epigenetic Alterations. In Cancer prevention research (Philadelphia, Pa.), 13, 357-366. doi:10.1158/1940-6207.CAPR-19-0496. https://pubmed.ncbi.nlm.nih.gov/31969344/
智鼠故事 
